✦ LIBER ✦

A Benefit-Risk Assessment of Imatinib in Chronic Myeloid Leukaemia and Gastrointestinal Stromal Tumours

✍ Scribed by Dominik Wolf, Holger Rumpold

Book ID: 120804619
Publisher: Springer International Publishing AG
Year: 2009
Tongue: English
Weight: 286 KB
Volume: 32
Category: Article
ISSN: 0114-5916
DOI: 10.2165/11314600-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-Risk Assessment of Sunitinib in

Benefit-Risk Assessment of Sunitinib in Gastrointestinal Stromal Tumours and Renal Cancer

✍ Nathalie Theou-Anton, Sandrine Faivre, Chantal Dreyer, Professor Eric Raymond 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 567 KB

Safety and efficacy of imatinib (STI571)

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

✍ Allan T van Oosterom; Ian Judson; Jaap Verweij; Sigrid Stroobants; Eugenio Donat 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 70 KB

Comparison of performance of various tum

Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib

✍ Shinagare, Atul B.; Jagannathan, Jyothi P.; Kurra, Vikram; Urban, Trinity; Manol 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Nilotinib in the treatment of advanced g

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

✍ M. Montemurro; P. Schöffski; P. Reichardt; H. Gelderblom; J. Schütte; J.T. Hartm 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Imatinib plasma trough levels in chronic

Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC

✍ Maya Koren-Michowitz; Yulia Volchek; Elizabeth Naparstek; Israel Gavish; Itai Le 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Evaluation of antileukaemic effects of r

Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia

✍ C. Sillaber; M. Mayerhofer; A. Böhm; A. Vales; A. Gruze; K. J. Aichberger; H. Es 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB